Mechanism involved in breast cancer’s spread to bone uncoveredFebruary 4th, 2011 - 3:05 pm ICT by ANI
Washington, Feb 4 (ANI): A team of Princeton University scientists has discovered a mechanism involved in breast cancer’s spread to bone, which may lead to a new treatment for the disease.
Cancer cells often travel throughout the body and cause new tumours in individuals with advanced breast cancer - a process called metastasis - commonly resulting in malignant bone tumours.
And what the new research has uncovered is the exact mechanism that lets the traveling tumour cells disrupt normal bone growth.
Breast cancer spreads to the bone in 70 to 80 percent of patients with advanced breast cancer, and it can also spread to the brain, lung and liver.
The team’s findings shows that breast tumour cells are able to give bone cells the wrong instructions through a process known as cell signaling -with disastrous effects for the patient.
The billions of cells in a living human body must communicate to develop, repair tissue, and effectively maintain normal physiological functions. Cell signaling is part of a complex system that enables them to do that.
But, in patients with cancer, the relationship between signaling molecules and the molecules that communicate with them has gone awry.
Signaling molecules are those that can be received and read by a cell through a receptor molecule on its surface. Once the signaling molecules connect with a receptor, their union sets off a process that leads to the receiving cell changing its behavior.
The sequence of events that follows involves a signaling pathway, which is a group of molecules that work together, one molecule activating the next until a specific function is carried out, such as renewing an organ’s cells. There are many such signaling pathways.
But in the case of metastatic breast cancer, a disruptive pathway is formed. The signaling molecule, also known as a ligand, connects with a receptor molecule on certain bone cells and activates a cellular pathway that ultimately disrupts healthy bone renewal.
Kang’s team identified the signaling molecule as Jagged1, and the receptor molecule as one that activates a cellular pathway known as the “Notch pathway.”
The study has been published online in the journal Cancer Cell. (ANI)
- New potential target for breast cancer therapy identified - Dec 23, 2010
- Silencing 'hedgehog' molecule halts cancer - Jun 06, 2011
- Normal healthy breast cells can help kill cancer cells - Apr 14, 2011
- Drug to reverse muscle loss due to cancer created - Aug 20, 2010
- New way to halt expansion of breast cancer stem cells discovered - Nov 24, 2010
- Small molecules 'could block cell proliferation in cancerous human tumor' - Apr 14, 2011
- Conventional theory of modern drug design challenged - Oct 11, 2010
- Key culprit in breast cancer metastasis identified - Feb 17, 2011
- Possible clues to tamoxifen resistance in breast cancer patients found - Mar 31, 2011
- Protein that makes local bladder cancer invasive found - May 15, 2010
- Breast stem cells' hormone sensitivity presents new drug target - Apr 12, 2010
- Wonder drug could kill all types of cancer - Jun 27, 2011
- Scientists discover potential new drug therapy for kidney diseases - Apr 27, 2011
- Why PSA levels reflect prostate cancer progression - Jan 14, 2011
- Drug used to treat asthma 'prevents spread of breast cancer' - Nov 04, 2010
Tags: advanced breast cancer, bone cells, bone growth, bone tumours, breast cancer, cancer cells, complex system, disastrous effects, exact mechanism, ligand, malignant bone, molecules, physiological functions, princeton university, receptor molecule, repair tissue, sequence of events, signaling pathways, tumour cells, university scientists